NICE kidney cancer drug decision26th August 2009
The National Institute for Clinical Excellence (NICE) has said doctors should not prescribe four kidney cancer drugs to new patients.
Although the Welsh health minister Edwina Hart had informed 22 health boards that they could give Avastin, Torisel, Sutent and Nexavar to patients, NICE said they were not "cost effective". A Welsh Assembly Government spokesperson said Ms Hart "expects clinicians in Wales to follow NICE recommendations for the use of these drugs now that the final guidance has been published".
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: NICE kidney cancer drug decision
Author: Jess Laurence
Article Id: 12488
Date Added: 26th Aug 2009